Anavex to Participate in Mizuho Therapeutics Conference

Conference to Feature Companies with Focus on Alzheimer’s, Parkinson’s and other Neurological Diseases NEW YORK, NY – September 14, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, other central nervous system (CNS) diseases,…